Exane Derivatives’s Ametek AME Stock Holding History

Exane Derivatives’s Portfolio AME Stock Details AME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2	Closed	-$266	–	780
2022 Q1	$266	Hold	2	–	–	﹤0.01%	932
2021 Q4	$294	Hold	2	–	–	﹤0.01%	815
2021 Q3	$248	Hold	2	–	–	﹤0.01%	998
2021 Q2	$270	Buy	+2	New	+$268	﹤0.01%	1002
2021 Q1	–	Sell	-21	Closed	-$2.54K	–	903
2020 Q4	$2.54K	Hold	21	–	–	﹤0.01%	604
2020 Q3	$2.09K	Hold	21	–	–	﹤0.01%	562
2020 Q2	$1.88K	Hold	21	–	–	﹤0.01%	510
2020 Q1	$1.51K	Hold	21	–	–	﹤0.01%	518
2019 Q4	$2.11K	Hold	21	–	–	﹤0.01%	493
2019 Q3	$1.93K	Hold	21	–	–	﹤0.01%	494
2019 Q2	$1.91K	Buy	+21	New	+$1.8K	﹤0.01%	514

Other funds holding AME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Exane Derivatives's AME Position: Q2 2022 in Review

Exane Derivatives sold out of Ametek (AME) in Q2 2022, closing a stake of 2 shares — an estimated $266 sold.

Exane Derivatives first reported a position in AME in Q2 2019 and held it in 11 quarters. The position peaked at $2.54K in Q4 2020. 743 funds tracked by Wall St. Rank hold AME as of Q2 2022.

Exane Derivatives reported no remaining Ametek position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 2 Ametek shares in Q2 2022, an estimated $266.
Exane Derivatives first reported a position in Ametek in Q2 2019 and held it in 11 quarters.
Exane Derivatives's Ametek position peaked at $2.54K in Q4 2020.
743 funds tracked by Wall St. Rank held Ametek as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.